Microplate Dx — Form D
Microplate Dx of GLASGOW, X0, a company, filed a Form D exempt-offering notice with the SEC on 2023-07-27. $1.4M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-07-27
- Form: D
- Accession: 0001985017-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Amount sold: $1.4M
- Investors: 6
- Date of first sale: 2023-07-04
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-488032
Issuer
- Name: Microplate Dx
- CIK: 0001985017
- Entity type: Other
- Jurisdiction: UNITED KINGDOM
- Incorporated: 2021
- Address: Tg528/Lgc Centre Office (Tg216), GLASGOW, X0, G1 1XL
- Phone: 07398858677
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| n/a Justin Radcliffe MBM SECRETARIAL SERVICES LIMITED | Executive Officer | EDINBURGH, X0 |
| Andrew Justin Radcliffe Porter | Director | Aberdeen, X0 |
| Stuart Matthew Hannah | Director | Glasgow, X0 |
| Stuart Matthew Hannah | Executive Officer | Glasgow, X0 |
| Poonam Matthew Malik | Director | Glasgow, X0 |
| Poonam Matthew Malik | Executive Officer | Glasgow, X0 |
Other filings by this issuer (1)
More